ENDRA LIFE SCIENCES INC. Earnings Per Share (Diluted)
ENDRA LIFE SCIENCES INC. (NDRA) reported Earnings Per Share (Diluted) of $0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. earnings per share, diluted for the quarter ending 2026-06-30 was $0.06.
- ENDRA LIFE SCIENCES INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$1.09.
- ENDRA LIFE SCIENCES INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$2.85.
- ENDRA LIFE SCIENCES INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$2.10.
- ENDRA LIFE SCIENCES INC. earnings per share, diluted for fiscal 2025 was -$8.93.
- ENDRA LIFE SCIENCES INC. earnings per share, diluted for fiscal 2024 was -$56.94.
- ENDRA LIFE SCIENCES INC. earnings per share, diluted for fiscal 2023 was -$2766.85.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.06 10-Q · filed 2026-08-14 | -$0.91 10-Q · filed 2026-08-14 | -$2.71 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$4.27 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2026-03-31 | -$1.09 10-Q · filed 2026-05-15 | -$3.88 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$5.94 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$7.71 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-12-31 | -$2.85 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$5.09 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$6.94 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$8.93 10-K · filed 2026-03-31 |
| 2025-09-30 | -$2.10 10-Q · filed 2025-11-14 | -$3.82 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$5.68 10-Q · filed 2025-11-14 | -$12.44 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-06-30 | -$1.71 10-Q · filed 2026-08-14 | -$3.55 10-Q · filed 2026-08-14 | -$10.60 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$17.01 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$1.86 10-Q · filed 2026-05-15 | -$9.45 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$16.83 derived: net income ÷ weighted average shares · filed 2026-05-15 | |
| 2024-12-31 | -$7.69 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$16.54 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$56.94 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$9.54 10-Q · filed 2025-11-14 | -$82.14 10-Q · filed 2025-11-14 | ||
| 2023-12-31 | -$2766.85 10-K/A · filed 2025-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |